Explore Protagenic Therapeutics' 8-K filing from February 21, 2025, detailing stock info and corporate developments. Key insights for investors and analysts.
Explore Occidental Petroleum's 8-K filing detailing common stock and warrants with a $0.20 par value. This report highlights important corporate activities as of March 3, 2025.
Explore Protagenic Therapeutics, Inc.'s 8-K filing from February 21, 2025, covering stock details, trading symbols, and entity information. Key insights into PTIX and PTIXW.
Explore Nukleus Inc.'s latest 8-K report from Feb 14, 2025, detailing stock performance, warrants, and corporate changes.
Explore Reliance Global Group's 8-K filing detailing stock and warrant information. Gain insights into their equity structure and SEC compliance as of February 18, 2025.
Explore GeneDx Holdings Corp.'s latest 8-K filing, revealing critical stock and warrant details, including pricing and classifications for investors.
Explore Fold Holdings, Inc.'s latest 8-K report detailing common stock, warrants, and financial metrics as of February 14, 2025. Stay informed on corporate developments!
Discover essential details from Trump Media & Technology Group's 8-K report, including stock and warrant specifics, SEC filing info, and contact details. Stay informed!
Explore ESS Tech, Inc.'s latest financial report detailing stock performance, warrant insights, and investment opportunities for February 13, 2025. Stay informed for strategic decisions!
Explore Datchat, Inc.'s 8-K filing detailing stock and warrant information as of February 11, 2025. Gain insights into capital management and growth expectations.
Explore Nutriband Inc's key financials as of February 13, 2025, including stock performance (NTRB, NTRBW) and corporate developments. Essential for investors and stakeholders.
Discover Safety Shot, Inc.'s latest 8-K report detailing stock and warrant information, crucial for investors. Learn about SHOT ticker, warrants, and financial metrics.